Faculty

Please select a name to view that person's profile information.

 
Justin Annes, M.D.

Clinical Genetics

Brigham and Women's Hospital


 

 

 

 
Gerard T. Berry, M.D.

Director, Medical Biochemical Genetics Specialty; Co-Director, Clinical Biochemical Genetics Specialty

Gerard T. Berry, MD is co-director of the Clinical Biochemical Genetics program and director of the Medical Biochemical Genetics program. Dr. Berry specializes in biochemical genetics (metabolism). He is the Diretor of the Metabolism Program at Children’s Hospital Boston and Professor of Pediatrics at Harvard Medical School. Dr. Berry holds Board Certifications in Pediatrics, Biochemical Genetics, and Pediatric Endocrinology.

 

 

 
Frederick Bieber, Ph.D.

Cytogenetics

Brigham and Women's Hospital

 

 

 
Gerald Cox, M.D.

Clinical Genetics

Children's Hospital Boston

 

 

 
Paola Dal Cin, Ph.D.

Cytogenetics

Brigham and Women's Hospital

 

 
Natasha Frank, M.D.

Clinical Genetics

Brigham and Women's Hospital

 

 
Birgit Funke, Ph.D.

Molecular Genetics

Laboratory for Molecular Medicine, Partners HealthCare Center for Personalized Genetic Medicine


Dr. Funke is an Associate Laboratory Director at the Laboratory for Molecular Medicine (LMM) as well as an as Instructor of Pathology at Harvard Medical School. She oversees genetic testing and test development in the area of cardiovascular disease diseases (inherited cardiomyopathies and congenital cardiovascular malformations). Her goal is to further define the genetic basis for these disorders and to develop comprehensive tests by using new emerging molecular technologies.

 

 
Judy Garber, M.D.

Director of Cancer Genetics and Prevention Disease Center

Dana-Farber Cancer Institute

Judy E. Garber, M.D., MPH, is Director of the new Cancer Genetics and Prevention Disease Center at the Dana-Farber Cancer Institute. She is attending physician at Dana-Farber’s Breast Oncology Center, an associate physician at Brigham and Women’s Hospital and an associate professor of Medicine at Harvard Medical School. Dr. Garber is currently president-elect of American Association for Cancer Research, the largest organization of cancer researchers in the world. She is a member of the NCI Board of Scientific Counselors and chairs the External Advisory Board of the SPORE in Breast Cancer at MD Anderson Cancer Center. She serves on the Scientific Advisory Board of the Breast Cancer Research Foundation and is a member or chair of the Data Safety Monitoring Committees of several international breast cancer clinical trials. Locally, she co-chairs a Dana-Farber/Harvard Cancer Center Institutional Review Board panel D, and is a member of the Personalized Cancer Medicine Partnership Steering Committee and Executive Committee for Clinical Research. To foster the incorporation of cancer genetics into clinical practice, Dr. Garber has played a major role in the development of national guidelines in genetics (American College of Medical Genetics) and medical oncology (American Society of Clinical Oncology and National Comprehensive Cancer Network.) Her research activities include the study of breast cancer risk assessment and communication, cancer genetics more broadly, and pharmacogenetics. She is also a leader in research into the characteristics and treatment of triple negative or basal-like breast cancer, the most common form in women with BRCA1 mutations. Her translational research focuses on the evaluation of novel agents targeting DNA repair defects in breast cancer, including PARP inhibitors for treatment and prevention of breast cancer and other BRCA-associated cancers.

 

 
Anne Giersch, Ph.D.

Cytogenetics

Brigham and Women's Hospital

 

 
David Harris, M.D.

Clinical Genetics

Children's Hospital Boston

http://specialists.childrenshospital.org

 

 
Ingrid Holm, M.D.

Clinical Genetics

Children's Hospital Boston

http://specialists.childrenshospital.org

 

 
Lewis B. Holmes, M.D.

Clinical Genetics

Massachusetts General Hospital

 

 
Mira Irons, M.D.

Clinical Genetics

Children's Hospital Boston

Mira Irons, M.D., was the Program Director of the Harvard Medical School Genetics Training Program from January of 2004 until February, 2012. Dr. Irons also served as the Director of the Clinical Genetics Residency from 2003-2011. Dr. Irons received her M.D. from Northwestern University Medical School in Chicago in 1980. She then completed a residency in pediatrics at Children's Memorial Hospital in Chicago. In 1983, she came to Boston to complete a genetics fellowship in the Harvard Medical School Genetics Training Program. After completing her genetics training in 1986, she worked in the Division of Genetics at Tufts University School of Medicine. In 1998, she joined the faculty at Children's Hospital Boston, where she currently serves as Associate Chief of the Division of Genetics and the Chief of Clinical Programs in the Division of Genetics. In this capacity, she oversees all clinical operations of the Division, including the clinical programs in Genetics and Metabolism at the Longwood campus as well as the Children's Hospital satellites.

Dr. Irons has a busy clinical practice, is the Director of the Neurofibromatosis Program and also sees patients in her general Genetics clinic, both at the Longwood campus and at the South Shore satellite office. She also serves as the Chair of the Internal Review Committee for the Children’s Hospital GME Program and is a member of the GME Executive Committee at the hospital.Dr. Irons has leadership roles in national Genetics and Medical organizations and/or serves on numerous national medical committees concerning genetics training and/or medical education. She is the President-Elect of the Association of Professors of Human and Medical Genetics, is the Chair of the Medical Genetics Residency Review Committee of the ACGME, is the Chair of the Education Committee and is the CME Officer for the American College of Medical Genetics, and is the ACMG representative to the Council of Medical Specialty Societies. She also is a member of the Accreditation Review Committee of the ACCME.

 

 
Philip James, M.D.

Clinical and Biochemical Genetics

Children's Hospital Boston

 

 
Natalia Leach, Ph.D.

Cytogenetics

Brigham and Women's Hospital

 

 
Chrles Lee, Ph.D.

Cytogenetics

Brigham and Women's Hospital

 

 
Harvey Levy, M.D.

Clinical and Biochemical Genetics

Children's Hospital Boston

Co-Director, Clinical Biochemical Genetics Specialty

Harvey Levy, M.D. is co-director of the HMS ABMG Clinical Biochemical Genetics program. Dr. Levy specializes in biochemical genetics (metabolism). He is Senior Physician in Medicine/Genetics at Children's Hospital Boston and Professor of Pediatrics at the Harvard Medical School. He was formerly Director of the Metabolic Program and currently serves as an attending physician within the program. Dr. Levy conducts clinical research in two areas of metabolism, phenylketonuria (PKU) and clinical and biochemical follow-up of newborn screening for metabolic disorders. He has very active research projects ongoing in those areas. 

 

 
Azra Ligon, Ph.D.

Cytogenetics

Brigham and Women's Hospital

Director, Clinical Cytogenetics Specialty

Azra H. Ligon, Ph.D., oversees training in the HMS ABMG Clinical Cytogenetics program. Dr. Ligon received her Ph.D. in Cancer Biology from the University of Texas/M.D. Anderson Cancer Center in 1995. She completed her Medical Genetics training at Baylor College of Medicine in 1997 and, after a research postdoctoral fellowship at Brigham and Women's Hospital (BWH), joined the Staff of the BWH Cytogenetics Laboratory in 1999 as an ABMG-certified Clinical Cytogeneticist. In 2003, she assumed leadership of the HMS ABMG Cytogenetics training program. Dr. Ligon's research activities include translation of basic research findings into clinical diagnostics, especially those relevant to the area of cancer diagnostics.l

 

 
Angela Lin M.D.

Clinical Genetics

Massachusetts General Hospital

Angela Lin trained in pediatric cardiology and medical genetics. As a clinical geneticist at MassGeneral Hospital for Children, her general genetics clinic is on Friday morning, supplemented by Cardiogenetics Clinic (including the MGH HHT Service), Craniofacial Clinic, Turner Syndrome Clinic, CHARGE Syndrome Clinic, and her interest in Costello and related Ras/MAPK syndromes. She works in the Active Malformation Surveillance Program at the BWH, and works at the MA Dept. Public Health as the geneticist for the Massachusetts Center for Birth Defects Prevention. Her clinical research interest focuses on syndrome delineation, cardiovascular anomalies in syndromes, and the epidemiology of CHDs. Dr. Lin is an Associate Editor for the American Journal of Medical Genetics. She works with several consumer advocacy groups including the Costello Syndrome Family Network and Turner Syndrome Society of America.

 

 

 
Neal Lindeman, M.D.

Pathology

Brigham and Women's Hospital

  

 
Deborah Marsden, M.D.

Biochemical Genetics

Children's Hospital Boston

 

 
David Miller, M.D., Ph.D.

Clinical and Molecular Genetics

Children's Hospital Boston

 

 
Cynthia Morton, Ph.D.

Cytogenetics

Brigham and Women's Hospital

Education Director

Cynthia Morton, Ph.D. is the William Lambert Richardson Professor of Obstetrics, Gynecology and Reproductive Biology and Professor of Pathology at Harvard Medical School, Associate Director of the Partners HealthCare Center for Personalized Genetic Medicine, Education Director for the HMS Genetics Training Program and Director of Cytogenetics at Brigham and Women's Hospital. Her research interests are in molecular cytogenetics, hereditary deafness, genetics of uterine leiomyomata, hereditary hearing loss, and cytogenetic approaches to gene discovery for developmental disorders. Her full-time academic laboratory contributed to the development of diagnostic testing for chromosome studies that cross the lifespan, which include preimplantation and prenatal diagnostics, perinatal and childhood studies in the evaluation of congenital and developmental disorders, infertility and pregnancy loss studies, and cytogenetics of leukemias, lymphomas and solid tumors. Her laboratory has been a major site for training laboratory geneticists in clinical cytogenetics.

 

 
Michael Murray, M.D.

Clinical Genetics

Brigham and Women's Hospital

Co-Director, Genetics Medicine Combined Residency, Site Director, Brigham and Women's Hospital Rotation

Dr. Murray is the Director of the BWH clinical genetics rotation. He is also the Co-Director of the BWH Genetics Medicine Residency Program along with Joel Katz, M.D. offering combined residency training in Internal Medicine and Medical Genetics. He supervises trainees in clinics and teaches in the Advanced Human Genetics course. His area of interest is the genetics of infectious diseases and connective tissue disease. Dr. Murray has developed and led the Brigham and Women's Family History Project and also developed an annual continuing medical education course offered since 2005, The Genetics and Genomic Basis of Adult Medicine. 

 

 
Edward Neilan, M.D., Ph.D.

Clinical and Biochemical Genetics

Children's Hospital Boston

 

 
Jonathan Picker, M.D.

Clinical Genetics

Children's Hospital Boston

 

 
Heidi Rehm, Ph.D.
Director, Clinical Molecular Genetics Specialty

Heidi Rehm was recruited in 2001 to build the Laboratory for Molecular Medicine at PCPGM and now serves as its Laboratory Director. She is a board-certified clinical molecular geneticist and Assistant Professor of Pathology at Harvard Medical School with appointments at Brigham & Women’s Hospital, Massachusetts General Hospital and Children’s Hospital Boston. Her undergraduate degree is from Middlebury College, her graduate degree in Genetics is from Harvard University and her postdoctoral and fellowship training was at Harvard
Medical School. Heidi has served as the Director of the ABMG Clinical Molecular Genetics Training Program at Harvard Medical School since 2006. In addition to running the LMM and the molecular training program, she also conducts research in hearing loss, Usher syndrome, cardiomyopathy and the use of IT in enabling personalized medicine. 

 

 
Amy Roberts, M.D.

Clinical Genetics

Children's Hospital Boston

Co-Director, Pediatrics/Clinical Genetic Residency Combined Training Program

Amy Roberts, M.D., CHB Department of Cardilogy and Department of Medicine, Division of Genetics
Dr. Roberts is a cardiovascular clinical geneticist and supervises trainees in the clinic and on the inpatient consult service. She also teaches in the Advanced Human Genetics course. She is conducting research on genotype-phenotype correlations in Noonan syndrome and congenital heart disease gene discovery. She co-directs the combined Pediatrics/Clinical Genetics residency training program with Ted Sectish, MD, Children's Hospital Boston.

 

 
Yiping Shen, Ph.D.

Clinical Molecular Genetics

Children's Hospital Boston

Massachusetts General Hospital

 

 
Katherine Sims, M.D.
Massachusetts General Hospital

 

 
Sharon Smith, M.D.

Clinical Genetics

Children's Hospital Boston

 

 
Joan Stoler, M.D.

Clinical Genetics

Children's Hospital Boston

 

 
David Sweetser, M.D.
Site Director, Massachusetts General Hospital Clinical Rotation

Clinical Genetics

Massachusetts General Hospital

 

 

 
Wen-Hann Tan, M.D.

Clinical Genetics

Children's Hospital Boston

http://children.photobooks.com

 

 
Joseph Thakuria, M.D.

Clinical Genetics

Massachusetts General Hospital

 

 
Christopher Walsh, M.D., Ph.D.

Chief, Division of Genetics

Children's Hospital Boston

 Dr. Walsh is the Chief of the Division of Genetics at Children's Hospital Boston as well as Professor of Neurology and Pediatrics at Harvard Medical School, Associate Member of the Broad Institute, and Senior Associate in Neurology at Beth Israel Deaconess Medical Center.  Dr. Walsh is interested in genes that regulate the development and function of the human cerebral cortex.  More information can be found here: www.walshlab.org

 

 
Stanislawa Weremowicz, Ph.D.

Cytogenetics

Brigham and Women's Hospital

 

 
Louise Wilkens-Haug, M.D.

Brigham and Women's Hospital

 

 
Bai-Lin Wu, Ph.D.

Molecular Genetics

Children's Hospital Boston

 

 
Winnie Xin, M.D.

Molecular Genetics

Massachusetts General Hospital